Anchor Capital Advisors LLC Has $53.75 Million Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

Anchor Capital Advisors LLC decreased its position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 4.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 418,592 shares of the medical equipment provider’s stock after selling 17,996 shares during the period. Zimmer Biomet Holdings accounts for approximately 2.0% of Anchor Capital Advisors LLC’s portfolio, making the stock its 4th largest position. Anchor Capital Advisors LLC owned 0.21% of Zimmer Biomet Holdings worth $53,747,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently bought and sold shares of ZBH. Enterprise Financial Services Corp increased its position in Zimmer Biomet Holdings by 0.3% in the second quarter. Enterprise Financial Services Corp now owns 2,646 shares of the medical equipment provider’s stock worth $340,000 after buying an additional 9 shares in the last quarter. Alpha Windward LLC increased its position in Zimmer Biomet Holdings by 1.1% in the first quarter. Alpha Windward LLC now owns 1,651 shares of the medical equipment provider’s stock worth $202,000 after buying an additional 18 shares in the last quarter. Sandy Spring Bank raised its stake in Zimmer Biomet Holdings by 1.7% in the first quarter. Sandy Spring Bank now owns 1,222 shares of the medical equipment provider’s stock valued at $149,000 after buying an additional 20 shares during the last quarter. Parkside Financial Bank & Trust raised its stake in Zimmer Biomet Holdings by 2.7% in the first quarter. Parkside Financial Bank & Trust now owns 839 shares of the medical equipment provider’s stock valued at $102,000 after buying an additional 22 shares during the last quarter. Finally, Cleararc Capital Inc. raised its stake in Zimmer Biomet Holdings by 0.5% in the first quarter. Cleararc Capital Inc. now owns 4,897 shares of the medical equipment provider’s stock valued at $598,000 after buying an additional 25 shares during the last quarter. 82.84% of the stock is currently owned by institutional investors.

Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) traded down 0.93% during mid-day trading on Friday, reaching $111.38. 1,036,099 shares of the company traded hands. Zimmer Biomet Holdings, Inc. has a 52-week low of $95.63 and a 52-week high of $133.49. The stock has a market capitalization of $22.52 billion, a PE ratio of 31.72 and a beta of 1.20. The stock’s 50 day moving average is $122.63 and its 200 day moving average is $121.15.

Zimmer Biomet Holdings (NYSE:ZBH) last posted its earnings results on Thursday, July 27th. The medical equipment provider reported $2.08 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $2.10 by $0.02. Zimmer Biomet Holdings had a return on equity of 16.70% and a net margin of 9.12%. The firm had revenue of $1.95 billion during the quarter, compared to the consensus estimate of $1.95 billion. During the same period in the previous year, the company posted $2.02 EPS. The firm’s revenue for the quarter was up 1.1% compared to the same quarter last year. On average, analysts anticipate that Zimmer Biomet Holdings, Inc. will post $8.24 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, September 22nd will be issued a $0.24 dividend. This represents a $0.96 annualized dividend and a dividend yield of 0.86%. The ex-dividend date of this dividend is Thursday, September 21st. Zimmer Biomet Holdings’s payout ratio is 27.59%.

ILLEGAL ACTIVITY NOTICE: This report was first published by BNB Daily and is owned by of BNB Daily. If you are accessing this report on another website, it was illegally copied and reposted in violation of international trademark & copyright legislation. The original version of this report can be read at https://www.baseball-news-blog.com/2017/08/19/zimmer-biomet-holdings-inc-nysezbh-is-anchor-capital-advisors-llcs-4th-largest-position-updated.html.

Several equities research analysts have recently issued reports on ZBH shares. Wells Fargo & Company lowered shares of Zimmer Biomet Holdings from an “outperform” rating to a “market perform” rating in a research report on Friday, April 28th. Needham & Company LLC increased their price objective on shares of Zimmer Biomet Holdings from $151.00 to $153.00 and gave the stock a “strong-buy” rating in a research report on Friday, April 28th. Oppenheimer Holdings, Inc. set a $132.00 price objective on shares of Zimmer Biomet Holdings and gave the stock a “buy” rating in a research report on Friday, April 28th. Canaccord Genuity reissued a “buy” rating on shares of Zimmer Biomet Holdings in a research report on Friday, April 28th. Finally, Goldman Sachs Group, Inc. (The) started coverage on shares of Zimmer Biomet Holdings in a research report on Tuesday, May 16th. They issued a “sell” rating and a $92.00 price objective for the company. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $136.90.

In other news, insider Sang Yi sold 17,731 shares of the company’s stock in a transaction dated Monday, June 12th. The shares were sold at an average price of $124.56, for a total value of $2,208,573.36. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP Tony W. Collins sold 16,986 shares of the company’s stock in a transaction dated Monday, July 31st. The stock was sold at an average price of $121.74, for a total transaction of $2,067,875.64. The disclosure for this sale can be found here. 1.07% of the stock is currently owned by corporate insiders.

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply